Cargando…

Tumor Cell‐Intrinsic SETD2 Deficiency Reprograms Neutrophils to Foster Immune Escape in Pancreatic Tumorigenesis

Genetic and epigenetic alterations play central roles in shaping the immunosuppressive tumor microenvironment (TME) to evade immune surveillance. The previous study shows that SETD2‐H3K36me3 loss promotes KRAS‐induced pancreatic tumorigenesis. However, little is known about its role in remodeling th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Niu, Ningning, Shen, Xuqing, Zhang, Li, Chen, Yueyue, Lu, Ping, Yang, Wenjuan, Liu, Mingzhu, Shi, Juanjuan, Xu, Dapeng, Tang, Yingying, Yang, Xiaotong, Weng, Yawen, Zhao, Xinxin, Wu, Lian‐Ming, Sun, Yongwei, Xue, Jing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9839845/ https://www.ncbi.nlm.nih.gov/pubmed/36453584 http://dx.doi.org/10.1002/advs.202202937

Ejemplares similares

SETD2 regulates chromatin accessibility and transcription to suppress lung tumorigenesis
por: Xie, Yuchen, et al.
Publicado: (2023)

A role for SETD2 loss in tumorigenesis through DNA methylation dysregulation
por: Javaid, Hira, et al.
Publicado: (2023)

Dynamic reprogramming of DNA methylation in SETD2-deregulated renal cell carcinoma
por: Tiedemann, Rochelle L., et al.
Publicado: (2015)

SETD1A drives stemness by reprogramming the epigenetic landscape in hepatocellular carcinoma stem cells
por: Chen, Jianxu, et al.
Publicado: (2023)

MiR-345-5p inhibits tumorigenesis of papillary thyroid carcinoma by targeting SETD7
por: Zhao, Ming, et al.
Publicado: (2019)

Lysine N-methyltransferase SETD7 promotes bladder cancer progression and immune escape via STAT3/PD-L1 cascade
por: Lv, Jiancheng, et al.
Publicado: (2023)

Recurrent SETD2 mutation in NPM1-mutated acute myeloid leukemia
por: Sun, Jiewen, et al.
Publicado: (2020)

PRMT5-dependent p53 escape in tumorigenesis
por: Li, Yan, et al.
Publicado: (2015)

Escape from IFN-γ-dependent immunosurveillance in tumorigenesis
por: Lin, Chiou-Feng, et al.
Publicado: (2017)

Epigenotype–genotype–phenotype correlations in SETD1A and SETD2 chromatin disorders
por: Lee, Sunwoo, et al.
Publicado: (2023)

Intrinsic motivation in virtual assistant interaction for fostering spontaneous interactions
por: Li, Chang, et al.
Publicado: (2021)

Intestinal Epithelial Cell-Intrinsic Deletion of Setd7 Identifies Role for Developmental Pathways in Immunity to Helminth Infection
por: Oudhoff, Menno J., et al.
Publicado: (2016)

Macrophage metabolic reprogramming and atherosclerotic plaque microenvironment: Fostering each other?
por: Xiao, Qi, et al.
Publicado: (2023)

EBV Infection and Its Regulated Metabolic Reprogramming in Nasopharyngeal Tumorigenesis
por: Yang, Tingting, et al.
Publicado: (2022)

Serine Metabolic Reprogramming in Tumorigenesis, Tumor Immunity, and Clinical Treatment
por: Shunxi, Wang, et al.
Publicado: (2023)

p53 connects tumorigenesis and reprogramming to pluripotency
por: Tapia, Natalia, et al.
Publicado: (2010)

Engulfment and cell motility protein 1 fosters reprogramming of tumor‐associated macrophages in colorectal cancer
por: Wen, Bo, et al.
Publicado: (2022)

NF1 heterozygosity fosters de novo tumorigenesis but impairs malignant transformation
por: Brosseau, Jean-Philippe, et al.
Publicado: (2018)

The HIST1 Locus Escapes Reprogramming in Cloned Bovine Embryos
por: Min, Byungkuk, et al.
Publicado: (2016)

Estrogen reprograms the activity of neutrophils to foster protumoral microenvironment during mammary involution
por: Chung, Hwa Hwa, et al.
Publicado: (2017)

Galectin-7 reprograms skin carcinogenesis by fostering innate immune evasive programs
por: Pinto, Nicolás A., et al.
Publicado: (2023)

Sequence specificity analysis of the SETD2 protein lysine methyltransferase and discovery of a SETD2 super-substrate
por: Schuhmacher, Maren Kirstin, et al.
Publicado: (2020)

Metabolic reprogramming: a bridge between aging and tumorigenesis
por: Drapela, Stanislav, et al.
Publicado: (2022)

Pan-cancer analysis of SETD2 mutation and its association with the efficacy of immunotherapy
por: Lu, Mingdong, et al.
Publicado: (2021)

On Foster-- Foster on /
Publicado: (2000)

Rv3091, An Extracellular Patatin-Like Phospholipase in Mycobacterium tuberculosis, Prolongs Intracellular Survival of Recombinant Mycolicibacterium smegmatis by Mediating Phagosomal Escape
por: Cui, Ziyin, et al.
Publicado: (2020)

Glucose metabolism reprogramming promotes immune escape of hepatocellular carcinoma cells
por: Zhang, Qiuyue, et al.
Publicado: (2023)

Proteomic analysis of SETD6 interacting proteins
por: Cohn, Ofir, et al.
Publicado: (2016)

Phenotypic characterization of SETD3 knockout Drosophila
por: Tiebe, Marcel, et al.
Publicado: (2018)

Insights into the stereoselectivity of human SETD7 methyltransferase
por: Tang, Bowen, et al.
Publicado: (2019)

Cancer Stem Cell Immunology: Key to Understanding Tumorigenesis and Tumor Immune Escape?
por: Bruttel, Valentin S., et al.
Publicado: (2014)

miRNAs: EBV Mechanism for Escaping Host’s Immune Response and Supporting Tumorigenesis
por: Židovec Lepej, Snježana, et al.
Publicado: (2020)

The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesis
por: Pomerantz, Mark M., et al.
Publicado: (2015)

Cell Reprogramming in Tumorigenesis and Its Therapeutic Implications for Breast Cancer
por: Chu, Pei-Yi, et al.
Publicado: (2019)

The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis
por: Aldiri, Issam, et al.
Publicado: (2017)

Author Correction: Sequence specificity analysis of the SETD2 protein lysine methyltransferase and discovery of a SETD2 super-substrate
por: Schuhmacher, Maren Kirstin, et al.
Publicado: (2020)

Histone Methyltransferase SETD1A Induces Epithelial-Mesenchymal Transition to Promote Invasion and Metastasis Through Epigenetic Reprogramming of Snail in Gastric Cancer
por: Wu, Jugang, et al.
Publicado: (2021)

H3K36 trimethylation mediated by SETD2 regulates the fate of bone marrow mesenchymal stem cells
por: Wang, Lijun, et al.
Publicado: (2018)

PTPRO represses colorectal cancer tumorigenesis and progression by reprogramming fatty acid metabolism
por: Dai, Weixing, et al.
Publicado: (2022)

Leukemia inhibitory factor drives glucose metabolic reprogramming to promote breast tumorigenesis
por: Yue, Xuetian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f9smj7mrtadjn6hjsfpt9fi4ve